Sambagan, Judelyn .

HRN: 28-85-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/14/2026
04/21/2026
IV
500mg
Q8h
S/P CS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: